Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
0.4936
-0.0123 (-2.43%)
Nov 17, 2026, 9:41 AM EST - Market open

Coherus Oncology Revenue

Coherus Oncology had revenue of $14.27M in the quarter ending September 30, 2026, with 23.36% growth. This brings the company's total for the last twelve months to $53.64M. In the year 2025, Coherus Oncology had annual revenue of $42.17M with 59.81% growth. That makes Coherus Oncology the 27,501st largest company in the world by revenue and 3,726th in the United States.

Revenue (ttm)
$53.64M
Revenue Growth
+59.81%
P/S Ratio
1.46
Revenue / Employee
$369,924
Employees
145
Market Cap
76.28M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202542.17M15.78M59.81%
Dec 31, 202426.39M-230.86M-89.74%
Dec 31, 2023257.24M46.20M21.89%
Dec 31, 2022211.04M-115.51M-35.37%
Dec 31, 2021326.55M-149.27M-31.37%
Dec 31, 2020475.82M119.75M33.63%
Dec 31, 2019356.07M--
Dec 31, 2018---
Dec 31, 20171.56M-188.55M-99.18%
Dec 31, 2016190.11M160.07M532.82%
Dec 31, 201530.04M-1.07M-3.42%
Dec 31, 201431.11M28.36M1,030.72%
Dec 31, 20132.75M852.00K44.87%
Dec 31, 20121.90M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Cellectis32.10M
Seer, Inc.14.08M
Rani Therapeutics Holdings6.58M
Kazia Therapeutics1.27M
Rallybio434.00K
Revenue Rankings